首页>
外国专利>
USE OF CETRORELIX FOR THE TREATMENT OF BENIGNA HYPERTROPHY OF PROSTATA AND CANCER DE PROSTATA.
USE OF CETRORELIX FOR THE TREATMENT OF BENIGNA HYPERTROPHY OF PROSTATA AND CANCER DE PROSTATA.
展开▼
机译：CETRORELIX在前列腺增生和前列腺癌治疗中的应用。
展开▼
页面导航
摘要
著录项
相似文献
摘要
THE INVENTION REFERS TO A PROCEDURE FOR THE THERAPEUTIC MANAGEMENT OF A BENIGN PROSTATIC HYPERPLASIA AND OF A PROSTATIC CANCER THAT USES CETRORELIX ONLY OR IN COMBINATION WITH THE INHIBITORS OF THE AL-REDUCTAASE OR WITH BLOCKING AGENTS OF THE ALLOCATORS. THE PROCEDURE REDUCES THE VOLUME OF THE PROSTATE AND AVOIDS THE COLLATERAL EFFECTS ASSOCIATED WITH THE TESTOSTERONE LEVELS THAT ARE LOCATED IN THE CASTRATION BAND. CETRORELIX IS ADMINISTERED IN DOSE OF BETWEEN 0.5 MG / DAY AND 20 MG / WEEK OR BETWEEN 0.014 MG / KG BODY WEIGHT PER DAY AND 0.30 MG / KG BODY WEIGHT PER WEEK OR AT LEVELS AROUND BETWEEN 25 AND 125 MG OF CETRORELIX PER MONTH OR BETWEEN 0.376 MG / KG AND 1.71 MG / KG PER MONTH. CETRORELIX CAN BE ADMINISTERED WITH INHIBITORS OF THE -REDUCTASE OR WITH BLOCKING AGENTS OF THE AL-RECEIVERS.
展开▼
